(Q38089106)

28 August 2017

title

Targeting autophagy to enhance oncolytic virus-based cancer therapy (English)

1 reference

28 August 2017

0 references

1 reference

Songshu Meng

1

1 reference

28 August 2017

Jiansheng Xu

series ordinal

2

1 reference

28 August 2017

Yantao Wu

series ordinal

3

1 reference

28 August 2017

Chan Ding

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

14 March 2013

1 reference

Expert Opinion on Biological Therapy

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

863-873

1 reference

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy and the Integrated Stress Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The regulation of autophagy - unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Mechanisms and regulation of autophagosome formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The dynamic nature of autophagy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Induction of autophagy and inhibition of tumorigenesis by beclin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Role of autophagy in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy as a therapeutic target in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Principles and current strategies for targeting autophagy for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Targeting autophagy during cancer therapy to improve clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy, Immunity, and Microbial Adaptations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

21 January 2018

Viruses and autophagy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Selective autophagy and viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Viruses and the autophagy machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Survival of parvovirus B19-infected cells by cellular autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy protects against Sindbis virus infection of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Early induction of autophagy in human fibroblasts after infection with human cytomegalovirus or herpes simplex virus 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Coronavirus replication complex formation utilizes components of cellular autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagosome supports coxsackievirus B3 replication in host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy in coxsackievirus-infected neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Adenoviruses induce autophagy to promote virus replication and oncolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Cellular autophagy machinery is not required for vaccinia virus replication and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Vaccinia virus leads to ATG12–ATG3 conjugation and deficiency in autophagosome formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Inhibition of autophagy enhances the effects of E1A-defective oncolytic adenovirus dl922-947 against glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Mre11 inhibition by oncolytic adenovirus associates with autophagy and underlies synergy with ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Avian reovirus triggers autophagy in primary chicken fibroblast cells and Vero cells to promote virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy induction by the pathogen receptor CD46.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

IRGM is a common target of RNA viruses that subvert the autophagy network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy and RNA virus interactomes reveal IRGM as a common target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Intelligent design: combination therapy with oncolytic viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Clinical development directions in oncolytic viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Oncolytic viruses and histone deacetylase inhibitors--a multi-pronged strategy to target tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The role of autophagy in cancer: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Lys05: a new lysosomal autophagy inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The antidepressants maprotiline and fluoxetine induce Type II autophagic cell death in drug-resistant Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy modulation for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.774365

10.1517/14712598.2013.774365

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference